BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 30215637)

  • 21. JAK/STAT inhibitors for the treatment of atopic dermatitis.
    Rodrigues MA; Torres T
    J Dermatolog Treat; 2020 Feb; 31(1):33-40. PubMed ID: 30703333
    [No Abstract]   [Full Text] [Related]  

  • 22. Oral Janus kinase inhibitors for atopic dermatitis.
    Mikhaylov D; Ungar B; Renert-Yuval Y; Guttman-Yassky E
    Ann Allergy Asthma Immunol; 2023 May; 130(5):577-592. PubMed ID: 36736457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic management of atopic dermatitis.
    Jarrell L
    Nurse Pract; 2024 Jun; 49(6):39-46. PubMed ID: 38941080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatments for Childhood Atopic Dermatitis: an Update on Emerging Therapies.
    Chu CY
    Clin Rev Allergy Immunol; 2021 Oct; 61(2):114-127. PubMed ID: 32607924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-4 and IL-13 Inhibition in Atopic Dermatitis.
    Matsunaga MC; Yamauchi PS
    J Drugs Dermatol; 2016 Aug; 15(8):925-9. PubMed ID: 27537991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging therapies for atopic dermatitis: JAK inhibitors.
    Cotter DG; Schairer D; Eichenfield L
    J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S53-S62. PubMed ID: 29248518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel therapies and the potential for a personalized approach to atopic dermatitis.
    Balakirski G; Novak N
    Curr Opin Allergy Clin Immunol; 2021 Aug; 21(4):368-377. PubMed ID: 34074875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New molecules for atopic dermatitis treatment beyond biological therapy.
    Freitas E; Torres T
    Curr Opin Allergy Clin Immunol; 2023 Jun; 23(3):210-215. PubMed ID: 37185825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Innovation in Atopic Dermatitis: From Pathogenesis to Treatment.
    Munera-Campos M; Carrascosa JM
    Actas Dermosifiliogr (Engl Ed); 2020 Apr; 111(3):205-221. PubMed ID: 31964499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dupilumab for treatment of atopic dermatitis.
    Seegräber M; Srour J; Walter A; Knop M; Wollenberg A
    Expert Rev Clin Pharmacol; 2018 May; 11(5):467-474. PubMed ID: 29557246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging treatments for atopic dermatitis.
    Katoh N
    J Dermatol; 2021 Feb; 48(2):152-157. PubMed ID: 32677122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel treatments for pediatric atopic dermatitis.
    Scott JB; Paller AS
    Curr Opin Pediatr; 2021 Aug; 33(4):392-401. PubMed ID: 34001717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibodies against interleukin 13 and interleukin 31RA in development for atopic dermatitis.
    Hamann CR; Thyssen JP
    J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S37-S42. PubMed ID: 29248521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spotlight on dupilumab in the treatment of atopic dermatitis: design, development, and potential place in therapy.
    D'Erme AM; Romanelli M; Chiricozzi A
    Drug Des Devel Ther; 2017; 11():1473-1480. PubMed ID: 28553077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atopic dermatitis - Perspectives and unmet medical needs.
    Buhl T; Werfel T
    J Dtsch Dermatol Ges; 2023 Apr; 21(4):349-353. PubMed ID: 36960846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New biological drugs in the treatment of inflammatory skin diseases].
    Mälkönen T
    Duodecim; 2014; 130(6):627-34. PubMed ID: 24724461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug evaluation review: dupilumab in atopic dermatitis.
    Hamilton JD; Ungar B; Guttman-Yassky E
    Immunotherapy; 2015; 7(10):1043-58. PubMed ID: 26598956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and Management of Conjunctivitis for the Dermatologist.
    Gooderham M; McDonald J; Papp K
    J Cutan Med Surg; 2018; 22(2):200-206. PubMed ID: 29191053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Development of new topical substances for the treatment of atopic dermatitis].
    Freimooser S; Traidl S; Werfel T
    Dermatologie (Heidelb); 2022 Jul; 73(7):514-519. PubMed ID: 35608634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asthma and Atopic Dermatitis: A Review of Targeted Inhibition of Interleukin-4 and Interleukin-13 As Therapy for Atopic Disease.
    Buzney CD; Gottlieb AB; Rosmarin D
    J Drugs Dermatol; 2016 Feb; 15(2):165-71. PubMed ID: 26885783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.